Lactobacillus casei ATCC 27139 enhances host innate immunity, and the J1 phage-resistant mutants of this strain lose the activity. A transposon insertion mutant library of L. casei ATCC 27139 was constructed, and nine J1 phage-resistant mutants out of them were obtained. Cloning and sequencing analyses identified three independent genes that were disrupted by insertion of the transposon element: asnH, encoding asparagine synthetase, and dnaJ and dnaK, encoding the molecular chaperones DnaJ and DnaK, respectively. Using an in vivo mouse model of Listeria infection, only asnH mutant showed deficiency in their ability to enhance host innate immunity, and complementation of the mutation by introduction of the wild-type asnH in the mutant strain recovered the immuno-augmenting activity. AsnH protein exhibited asparagine synthetase activity when the lysozyme-treated cell wall extracts of L. casei ATCC 27139 was added as substrate. The asnH mutants lost the thick and rigid peptidoglycan features that are characteristic to the wild-type cells, indicating that AsnH of L. casei is involved in peptidoglycan biosynthesis. These results indicate that asnH is required for the construction of the peptidoglycan composition involved in the immune-activating capacity of L. casei ATCC 27139.
References
[1]
Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16: 658–672.
[2]
Shida K, Nanno M (2008) Probiotics and immunology: separating the wheat from the chaff. Trends Immunol 29: 565–573.
[3]
Takeda K, Okumura K (2007) Effects of a Fermented Milk Drink Containing Lactobacillus casei Strain Shirota on the Human NK-Cell Activity. J Nutr 137: 791S–793S.
[4]
Takeda K, Suzuki T, Shimada SI, Shida K, Nanno M, et al. (2006) Interleukin-12 is involved in the enhancement of human natural killer cell activity by Lactobacillus casei Shirota. Clin Exp Immunol 146: 109–115.
[5]
Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, et al. (1995) Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. The BLP Study Group. Eur Urol 27: 104–109.
[6]
Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, et al. (2002) Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68: 273–280.
[7]
Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, et al. (1985) Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. J Clin Lab Immunol 17: 91–97.
[8]
Yokokura T, Nomoto K, Shimizu T, Nomoto K (1986) Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei. Infect Immun 52: 156–160.
[9]
Miake S, Nomoto K, Yokokura T, Yoshikai Y, Mutai M (1985) Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice. Infect Immun 48: 480–485.
[10]
Matsuzaki T, Hashimoto S, Yokokura T (1996) Effects on antitumor activity and cytokine production in the thoracic cavity by intrapleural administration of Lactobacillus casei in tumor-bearing mice. Med Microbiol Immunol (Berl) 185: 157–161.
[11]
Kato I, Kobayashi S, Yokokura T, Mutai M (1981) Antitumor activity of Lactobacillus casei in mice. Gann 72: 517–523.
[12]
Matsuzaki T, Yokokura T (1987) Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei. Cancer Immunol Immunother 25: 100–104.
[13]
Matsuzaki T, Yokokura T, Azuma I (1987) Antimetastatic effect of Lactobacillus casei YIT9018 (LC 9018) on a highly metastatic variant of B16 melanoma in C57BL/6J mice. Cancer Immunol Immunother 24: 99–105.
[14]
Matsuzaki T, Yokokura T, Azuma I (1985) Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol Immunother 20: 18–22.
[15]
Shimizu-Kadota M, Kiwaki M, Sawaki S, Shirasawa Y, Shibahara-Sone H, et al. (2000) Insertion of bacteriophage phiFSW into the chromosome of Lactobacillus casei strain Shirota (S-1): characterization of the attachment sites and the integrase gene. Gene 249: 127–134.
[16]
Kim YG, Ohta T, Takahashi T, Kushiro A, Nomoto K, et al. (2006) Probiotic Lactobacillus casei activates innate immunity via NF-κB and p38 MAP kinase signaling pathways. Microbes Infect 8: 994–1005.
[17]
Capra ML, Quiberoni A, Reinheimer J (2006) Phages of Lactobacillus casei/paracasei: response to environmental factors and interaction with collection and commercial strains. J Appl Microbiol 100: 334–342.
[18]
Ito M, Kim YG, Tsuji H, Kiwaki M, Nomoto K, et al. (2010) A practical random mutagenesis system for probiotic Lactobacillus casei using Tn5 transposition complexes. J Appl Microbiol 109: 657–666.
[19]
Byeon WH, Weisblum B (1984) Post-transcriptional regulation of chloramphenicol acetyl transferase. J Bacteriol 158: 543–550.
[20]
Mitani Y, Meng X, Kamagata Y, Tamura T (2005) Characterization of LtsA from Rhodococcus erythropolis, an enzyme with glutamine amidotransferase activity. J Bacteriol 187: 2582–2591.
[21]
Larsen TM, Boehlein SK, Schuster SM, Richards NG, Thoden JB, et al. (1999) Three-dimensional structure of Escherichia coli asparagine synthetase B: a short journey from substrate to product. Biochemistry 38: 16146–16157.
[22]
Mei B, Zalkin H (1989) A cysteine-histidine-aspartate catalytic triad is involved in glutamine amide transfer function in purF-type glutamine amidotransferases. J Biol Chem 264: 16613–16619.
[23]
Miller MT, Bachmann BO, Townsend CA, Rosenzweig AC (2001) Structure of β-lactam synthetase reveals how to synthesize antibiotics instead of asparagine. Nat Struct Biol 8: 684–689.
[24]
Boehlein SK, Richards NG, Walworth ES, Schuster SM (1994) Arginine 30 and asparagine 74 have functional roles in the glutamine dependent activities of Escherichia coli asparagine synthetase B. J Biol Chem 269: 26789–26795.
[25]
Veiga P, Erkelenz M, Bernard E, Courtin P, Kulakauskas S, et al. (2009) Identification of the asparagine synthase responsible for -Asp amidation in the Lactococcus lactis peptidoglycan interpeptide crossbridge. J Bacteriol 191: 3752–3757.
[26]
Billot-Klein D, Legrand R, Schoot B, van Heijenoort J, Gutmann L (1997) Peptidoglycan structure of Lactobacillus casei, a species highly resistant to glycopeptide antibiotics. J Bacteriol 179: 6208–6212.
[27]
Ohashi T, Minamishima Y, Yokokura T, Mutai M (1989) Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei. Biotherapy 1: 89–95.
[28]
Ang D, Liberek K, Skowyra D, Zylicz M, Georgopoulos C (1991) Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266: 24233–24236.
[29]
Hughes CA, Beard HS, Matthews BF (1997) Molecular cloning and expression of two cDNAs encoding asparagine synthetase in soybean. Plant Mol Biol 33: 301–311.
[30]
Humbert R, Simoni RD (1980) Genetic and biomedical studies demonstrating a second gene coding for asparagine synthetase in Escherichia coli. J Bacteriol 142: 212–220.
[31]
Zalkin H (1993) The amidotransferases. Adv Enzymol Relat Areas Mol Biol 66: 203–309.
[32]
Ren H, Liu J (2006) AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs. Antimicrob Agents Chemother 50: 250–255.
[33]
Hirasawa T, Wachi M, Nagai K (2000) A mutation in the Corynebacterium glutamicum ltsA gene causes susceptibility to lysozyme, temperature-sensitive growth, and -glutamate production. J Bacteriol 182: 2696–2701.
[34]
Courtin P, Miranda G, Guillot A, Wessner F, Mezange C, et al. (2006) Peptidoglycan structure analysis of Lactococcus lactis reveals the presence of an ,-carboxypeptidase involved in peptidoglycan maturation. J Bacteriol 188: 5293–5298.
[35]
Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407–477.
[36]
Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340: 783–795.
[37]
Fernandez EM, Valenti V, Rockel C, Hermann C, Pot B, et al. (2011) Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut 60: 1050–1059.
[38]
Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 278: 5509–5512.
[39]
Yokokura T (1977) Phage receptor material in Lactobacillus casei. J Gen Microbiol 100: 139–145.
[40]
Hashimoto S, Nomoto K, Nagaoka M, Yokokura T (1987) In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants. Cancer Immunol Immunother 24: 1–7.
[41]
Smelt MJ, de Haan BJ, Bron PA, van Swam I, Meijerink M, et al. (2013) The impact of Lactobacillus plantarum WCFS1 teichoic acid -alanylation on the generation of effector and regulatory T-cells in healthy mice. PLoS One 8: e63099.
[42]
Liu Y, Wang Y, Yamakuchi M, Isowaki S, Nagata E, et al. (2001) Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-κB activation. Infect Immun 69: 2788–2796.
[43]
Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274: 17406–17409.
[44]
Faure E, Thomas L, Xu H, Medvedev A, Equils O, et al. (2001) Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J Immunol 166: 2018–2024.
[45]
Matsuguchi T, Takagi K, Musikacharoen T, Yoshikai Y (2000) Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 95: 1378–1385.
[46]
Kurt-Jones EA, Mandell L, Whitney C, Padgett A, Gosselin K, et al. (2002) Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100: 1860–1868.
[47]
Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, et al. (1999) Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163: 1–5.
